Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05827718 |
Other study ID # |
962643 |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
October 30, 2023 |
Est. completion date |
March 2026 |
Study information
Verified date |
December 2023 |
Source |
University of Pennsylvania |
Contact |
Alexander Fanaroff, MD, MHS |
Phone |
301-455-4108 |
Email |
alexander.fanaroff[@]pennmedicine.upenn.edu |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are
safe and effective. Usually only a small number of eligible patients enroll. This is because
trials require people to consent to be enrolled and randomized. Black and Hispanic people are
more likely to develop heart disease. They are also more likely to have risk factors for
heart disease that are not controlled. Yet they are very under-represented in heart disease
trials. This raises concerns about if trial results can be applied to the general population.
Trial sponsors are required to enroll patients that reflect the racial and ethnic diversity
of real-world people. Black and Hispanic people continue to enroll in trials at a lower rate.
The goal of this study is to conduct a series of small randomized trials to test recruitment
strategies to increase how many Black and Hispanic people enroll in heart disease clinical
trials without diminishing trust. The investigators will test different recruitment
strategies for participant enrollment in a few different areas. They will study the method of
outreach, the way messages are framed, defaults, and enrollment incentives. They will run
smaller recruitment strategy trials within larger parent trials (e.g. Penn Medicine Biobank
cohort study). They will run a small recruitment strategy trial to test each approach and
then include what they learned in the next small trial.
Description:
Randomized clinical trials (RCTs) are the gold standard for determining the effectiveness and
safety of drugs, medical devices, or healthcare delivery interventions. However, because RCTs
require participants to consent to enrollment and randomization, typically only a minority of
eligible patients enroll, raising concerns regarding the generalizability of trial results.
Though Black and Hispanic individuals are disproportionately more likely to have uncontrolled
risk factors for cardiovascular disease and to develop cardiovascular disease, they are
substantially underrepresented in cardiovascular RCTs. In one review of 143 cardiovascular
clinical trials conducted between 2008 and 2017, just 2.1% of enrollees were Black and 2.1%
were Hispanic. Such low rates of enrollment have persisted despite mandates by funding and
regulatory authorities that trial sponsors aim to enroll patient populations in RCTs that
reflect the racial and ethnic diversity of real-world populations of patients with the
disease under study. The failure of these recommendations to meaningfully increase the racial
and ethnic diversity of RCT participants indicates a need for new and innovative strategies.
Behavioral economics is a scientific field of inquiry that incorporates principles from
economics and psychology to better describe how individuals behave and to influence their
behavior. While standard economics assumes that individuals are rational expected utility
maximizers, behavioral economics recognizes that individuals' decision-making is limited by
thinking capacity, available information, and time. As such, decision-making is governed by
heuristics, or cognitive shortcuts. For instance, rather than trying to assess the myriad
risks and benefits of participating in a research study, individuals may decide not to
participate because the invitation to participate isn't from someone whose name they
recognize or a perception that people like themselves do not participate. Knowledge of common
heuristics can be leveraged to influence choices by modifying the context in which decisions
are made, such as by changing default options or how choices are framed. Marketing studies
have demonstrated the effectiveness of appeals to altruism, perceived scarcity ("This product
is desirable because it is hard to get"), and social proof ("Are people like me using this
product or service?") in increasing responsiveness to outreach, and these techniques can be
re-purposed to increase representativeness of RCTs. Challenging social circumstances can be
thought of as a "tax" on individuals' cognitive bandwidth, underscoring the opportunity to
increase RCTs' racial and ethnic diversity by simplifying the enrollment process to make it
easier to enroll, increasing the trustworthiness of communications, and reframing
participation to make it more attractive.
The reasons for low enrollment of patients from underrepresented racial and ethnic groups in
cardiovascular RCTs are multifactorial. Typically, RCTs that enroll vast majorities of
patients from global regions with few Black or Hispanic patients will not enroll populations
representative of U.S. demographics. Moreover, Black and Hispanic individuals are often less
willing than White individuals to participate in RCTs; they are more likely to face barriers
in accessing health services and to have mistrust of medical researchers, due to concerns
about historic and ongoing scientific misconduct.
Newer means of communication, including patient portals, may increase or decrease
representativeness depending on how they are deployed. However, few studies have
systematically evaluated recruitment strategies in randomized fashion. As with any
intervention, the effectiveness of different recruitment strategies is best assessed by
testing different alternatives in RCTs. Accordingly, the overarching goal of this project is
to conduct a series of RCTs to rigorously, systematically, and iteratively test strategies
designed to increase enrollment of Black and Hispanic individuals in prospective cohort
studies without diminishing trust. The investigators will embed RCTs of changes to the
decision-making context, or "nudges," in the context of recruitment for prospective cohort
studies because these studies' large sample size will facilitate accelerated rapid-cycle
testing of multiple nudges, with results from each recruitment RCT incorporated in the next
round of testing. Since the nudges are layered on top of existing cohort recruitment methods
- changing only the method of outreach, message framing, or incentive structure - they are
low cost, and the number of nudges that can be tested is bound primarily by the size of the
cohort to be enrolled. The investigative group is uniquely positioned to conduct these
studies. First, the investigators have conducted some of the only RCTs evaluating different
RCT recruitment strategies. Second, they have established relationships with multiple cohort
studies enrolling tens of thousands of patients with cardiovascular diseases. Third, they
have extensive experience applying insights from behavioral economics to health behaviors.
The RCTs will sequentially test different strategies for participant enrollment in the
following realms: method of outreach, message framing and default settings, and enrollment
incentives. The primary outcome of each recruitment RCT will be the enrollment fraction of
Black and Hispanic participants - the number of Black and Hispanic patients enrolled divided
by the number attempted to be contacted. Because Black and Hispanic populations are
heterogeneous, the investigators will also report the effect of each approach on enrollment
fraction stratified according to socioeconomic status (SES), assessed using the Area
Deprivation Index, a community-level SES metric. Other key secondary outcomes will include
the overall enrollment fraction and the population-to-prevalence ratio, defined as the
enrollment fraction of Black and Hispanic patients divided by the overall enrollment
fraction. Across sequential RCTs of behaviorally-informed recruitment strategies, the
investigators will accomplish the following specific aims:
Aim 1. To evaluate the effect of method of outreach on representativeness. First, patients
will all receive a message via email (or traditional mail, if no email address is on file)
with information about a cohort study and how to enroll and will be randomized to receive an
additional message via text message or patient portal. In a subsequent RCT, potential
participants will be randomized to receive this message from their personal clinician or from
the research team.
Aim 2. To evaluate the effect of message framing across three domains - appeal to altruism
versus a standard approach to recruitment, social proof versus scarcity versus neither, and
opt-in versus opt-out - on representativeness. The investigators will evaluate each different
framing choice in 3 sequential RCTs that will be embedded in existing large cohort studies.
Aim 3. To evaluate different incentive structures on representativeness. In a final 2 × 2
RCT, the investigators will evaluate gain- versus loss-framed incentives and guaranteeing the
full incentive versus providing part of the incentive as chance to win a lottery.
Participants will be randomized to a small, guaranteed incentive or a smaller guaranteed
incentive plus a 1 in 40 chance to win a larger amount, and further randomized to be promised
this money ('gain frame') or have it deposited in a virtual account ('loss frame').